1-3 of 3
Bassem I. Zaki, MD
Close
Sort by
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival

Cristiana A Costa, DO, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd A MacKenzie, PhD, Anne W Beaven, MD, Frederick Lansigan, MD
Journal: Blood
Blood (2016) 128 (22): 1793.
https://doi.org/10.1182/blood.V128.22.1793.1793
Published: 2016
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naïve Follicular Lymphoma: Results of Fol-Brite

Frederick Lansigan, MD, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie L Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd MacKenzie, PhD, Anne W Beaven, MD
Journal: Blood
Blood (2014) 124 (21): 1733.
https://doi.org/10.1182/blood.V124.21.1733.1733
Published: 2014
Journal Articles

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

Pamela Ely, MD, PhD, Diane M. Stearns, ARNP, Bassem I. Zaki, MD, Thomas F. Fitzmaurice, Ph.D, Marc Gautier, MD, Christopher H. Lowrey, MD, Elizabeth M. Bengtson, MD, John M. Hill, MD, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Lynn Root, RN, Susan Webber, MT (ASCP), BB, Zbigniew M. Szczepiorkowski, MD, Ph.D, Kenneth R. Meehan, MD
Journal: Blood
Blood (2005) 106 (11): 5517.
https://doi.org/10.1182/blood.V106.11.5517.5517
Published: 2005